First Eagle Investment Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,414	Closed	-$214K	–	152
2019 Q2	$214K	Hold	8,414	–	–	﹤0.01%	148
2019 Q1	$358K	Hold	8,414	–	–	﹤0.01%	151
2018 Q4	$122K	Sell	8,414 -714	-8%	-$29.1K	﹤0.01%	165
2018 Q3	$639K	Hold	9,128	–	–	﹤0.01%	161
2018 Q2	$677K	Hold	9,128	–	–	﹤0.01%	160
2018 Q1	$869K	Hold	9,128	–	–	﹤0.01%	160
2017 Q4	$1.18M	Hold	9,128	–	–	﹤0.01%	221
2017 Q3	$620K	Hold	9,128	–	–	﹤0.01%	258
2017 Q2	$863K	Hold	9,128	–	–	﹤0.01%	225
2017 Q1	$1.31M	Sell	9,128 -7,301	-44%	-$1.04M	﹤0.01%	214
2016 Q4	$2.08M	Buy	16,429 +9,286	+130%	+$1.29M	0.01%	199
2016 Q3	$1.09M	Hold	7,143	–	–	﹤0.01%	239
2016 Q2	$822K	Buy	+7,143	New	+$791K	﹤0.01%	256
2015 Q2	–	Sell	-2,800	Closed	-$1.44M	–	330
2015 Q1	$1.44M	Sell	2,800 -3,935	-58%	-$1.99M	﹤0.01%	219
2014 Q4	$3.61M	Buy	+6,735	New	+$3.03M	0.01%	190
2014 Q3	–	Sell	-952	Closed	-$1.3M	–	353
2014 Q2	$1.3M	Sell	952 -94	-9%	-$109K	﹤0.01%	225
2014 Q1	$1.45M	Sell	1,046 -97	-8%	-$113K	﹤0.01%	195
2013 Q4	$1.14M	Buy	1,143 +191	+20%	+$197K	﹤0.01%	204
2013 Q3	$992K	Buy	+952	New	+$1.02M	﹤0.01%	218

Other funds holding VIRX